Theriva Biologics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $13.0M | $10.0M |
| FY2013 | — | $15.2M | $14.6M |
| FY2014 | — | $9.6M | $17.5M |
| FY2015 | — | $16.1M | $20.8M |
| FY2016 | — | $3.8M | $19.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $13.0M | $10.0M |
| FY2013 | — | $15.2M | $14.6M |
| FY2014 | — | $9.6M | $17.5M |
| FY2015 | — | $16.1M | $20.8M |
| FY2016 | — | $3.8M | $19.1M |